These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1720111)

  • 21. [Sabal serrulata extract in the management of symptoms of prostatic hypertrophy].
    Kondás J; Philipp V; Diószeghy G
    Orv Hetil; 1997 Feb; 138(7):419-21. PubMed ID: 9091843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventive and curative action of a bark extract from an African plant, Pygeum africanum, on experimental prostatic adenoma in rats].
    Thieblot L; Berthelay S; Berthelay J
    Therapie; 1971; 26(3):575-80. PubMed ID: 4107111
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current phytotherapeutic agents in the treatment of prostatic diseases].
    Rocchietta S
    Minerva Med; 1977 Dec; 68(63):4261-4. PubMed ID: 74814
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experimentation with V 1326 in prostatic disorders].
    Lange ; Muret
    Bord Med; 1970 Nov; 3(11):2807-8 passim. PubMed ID: 4101700
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy].
    Ollé Carreras J
    Arch Esp Urol; 1987 Jun; 40(5):310-3. PubMed ID: 2444169
    [No Abstract]   [Full Text] [Related]  

  • 26. [Standardized extract of Pygeum africanum in the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo].
    Bassi P; Artibani W; De Luca V; Zattoni F; Lembo A
    Minerva Urol Nefrol; 1987; 39(1):45-50. PubMed ID: 2441479
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytomorphologic studies of benign prostate hyperplasia treated with extract radicis urticae (ERU). Preliminary results].
    Ziegler H
    Fortschr Med; 1982 Oct; 100(39):1832-4. PubMed ID: 6185399
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Chir (Paris); 1994 Oct; 131(10):445-9. PubMed ID: 7532181
    [No Abstract]   [Full Text] [Related]  

  • 29. African plum and benign prostatic hypertrophy.
    Strong KM
    J Herb Pharmacother; 2004; 4(1):41-6. PubMed ID: 15273076
    [No Abstract]   [Full Text] [Related]  

  • 30. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of prostatic hypertrophy with eviprostat].
    Kubo Y; Inoue S; Ono T; Yasui A
    Hinyokika Kiyo; 1966 Dec; 12(12):1463-7. PubMed ID: 4167083
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prostatic adenoma. The conservative therapy with urtica extract].
    Barsom S; Bettermann AA
    ZFA (Stuttgart); 1979 Nov; 55(33):1947-50. PubMed ID: 93356
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
    Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
    Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year.
    Romics I; Schmitz H; Frang D
    Int Urol Nephrol; 1993; 25(6):565-9. PubMed ID: 7513678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical treatment of the prostatism syndrome. Comparative study].
    Martínez Agulló E; Gallego Gómez J; Jiménez Cruz FJ
    Arch Esp Urol; 1987 May; 40(4):247-53. PubMed ID: 2443084
    [No Abstract]   [Full Text] [Related]  

  • 37. Managing benign prostate disease.
    Eddy B; Anderson C
    Practitioner; 2002 Dec; 246(1641):812-5, 817-9. PubMed ID: 12489357
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
    Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y
    Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retreatment rate after surgical and non-surgical treatments.
    de Wildt MJ; de la Rosette JJ; Debruyne FM
    Prog Clin Biol Res; 1994; 386():597-613. PubMed ID: 7528429
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].
    Vontobel HP; Herzog R; Rutishauser G; Kres H
    Urologe A; 1985 Jan; 24(1):49-51. PubMed ID: 2580383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.